JAGDEEP GAREWAL: Open Payments
NPI 1427190487 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,813 in 37 payments from 10 companies in 2025. Trend: 2023 $1,933 · 2024 $1,307 · 2025 $1,813
Food & beverage: $1,698Education: $115
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $304 |
| Janssen Pharmaceuticals, Inc | 4 | $265 |
| Otsuka America Pharmaceutical, Inc. | 2 | $235 |
| Teva Pharmaceuticals USA, Inc. | 7 | $201 |
| E.R. Squibb & Sons, L.L.C. | 3 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $163 |
| Vanda Pharmaceuticals Inc. | 2 | $145 |
| Neurocrine BioSciences, Inc. | 2 | $145 |
| ABBVIE INC. | 1 | $125 |
| Lundbeck LLC | 3 | $66 |
Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, LYBALVI, ABILIFY ASIMTUFII, FANAPT, INGREZZA, ARISTADA.
Industry payments across CA — which companies pay providers there.
